(2005) showed a 2.5-fold decrease in the rate of fat oxidation, compared to control, during moderate intensity exercise (65% of VO2 max) when free carnitine availability was reduced by 50% as a result of pyruvate, and therefore acetyl-CoA, production being increased as a result of pre-exercise muscle glycogen content being elevated
76 However, it is not clear that feeding GSH is associated with higher ocular levels of this antioxidant
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: clinical and therapeutic implications
Convenience and consistency
"Hepatic lipase: a pro- or anti-atherogenic protein?"
At the time of development for rulemaking on the CY 2025 PFS, we did not believe it was necessary to clarify at 428.202(c)(2) or (c)(4) that the payment amount benchmark period for a subsequently approved drug also must be no earlier than calendar year 2021, since a subsequently approved drug is by definition a Part D rebatable drug first approved or licensed by the FDA after October 1, 2021
